Patents by Inventor Seo Jung HAN

Seo Jung HAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL PHTHALAZINE DERIVATIVE HAVING ECTONUCLOEOTIDE PYROPHOSPHATASE/PHOSPHODIESTE RASE INHIBITORY ACTIVITY, AND USE THEREOF
    Publication number: 20230159469
    Abstract: The present invention relates to a compound for inhibiting ENPP1, a composition for inhibiting ENPP1, and a novel phthalazine derivative compound related to a method for inhibiting ENPP1, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof.
    Type: Application
    Filed: May 7, 2021
    Publication date: May 25, 2023
    Applicant: TXINNO BIOSCIENCE INC.
    Inventors: Seo Jung Han, Jun Won Choi, Sang Hee Lee, Chan Sun Park, Sung Joon Kim, Jae Eun Cheong, Hee Jin Jeong, Do Hee Oh
  • PYRROLOPYRIMIDINE DERIVATIVE HAVING ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE INHIBITORY ACTIVITY AND USE THEREOF
    Publication number: 20220411420
    Abstract: Disclosed is a novel pyrrolopyrimidine derivative compound, a tautomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a stereoisomer thereof, associated with a compound for inhibiting ENPP1, a composition for inhibiting ENPP1, and a method of inhibiting ENPP1.
    Type: Application
    Filed: March 29, 2022
    Publication date: December 29, 2022
    Inventors: Seo Jung HAN, Sang Hee LEE, Hee Jin JEONG, Hye Lim LEE, Chan Sun PARK, Sung Joon KIM
  • Pyrimido[4,5-d]pyrimidin-2-one derivatives as protein kinase inhibitors
    Patent number: 11530221
    Abstract: Disclosed are a compound selected from novel pyrimido[4,5-d]pyrimidin-2-one derivative compounds having excellent anti-proliferative activity against cancer cells, pharmaceutically acceptable salts thereof, hydrates thereof and stereoisomers thereof, a method for preparing the compound, a pharmaceutical composition for preventing, alleviating or treating cancer metastasis and proliferative diseases containing the compound as an active ingredient, and an anticancer composition against cancer cells, containing the compound as an active ingredient. The compounds of this invention exhibit most excellent selective inhibitory activity against LCK and anti-proliferative activity against cancer cells, thus being useful for inhibiting cancer cells, and for preventing or treating cancer metastasis and proliferative diseases.
    Type: Grant
    Filed: August 25, 2020
    Date of Patent: December 20, 2022
    Assignee: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Seo Jung Han, Tae Bo Sim, Do Hee Oh, Jae Eun Cheong, Dong Keon Hwang
  • PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE DERIVATIVES AS PROTEIN KINASE INHIBITORS
    Publication number: 20210061810
    Abstract: Disclosed are a compound selected from novel pyrimido[4,5-d]pyrimidin-2-one derivative compounds having excellent anti-proliferative activity against cancer cells, pharmaceutically acceptable salts thereof, hydrates thereof and stereoisomers thereof, a method for preparing the compound, a pharmaceutical composition for preventing, alleviating or treating cancer metastasis and proliferative diseases containing the compound as an active ingredient, and an anticancer composition against cancer cells, containing the compound as an active ingredient. The compounds of this invention exhibit most excellent selective inhibitory activity agaist LCK and anti-proliferative activity against cancer cells, thus being useful for inhibiting cancer cells, and for preventing or treating cancer metastasis and proliferative diseases.
    Type: Application
    Filed: August 25, 2020
    Publication date: March 4, 2021
    Inventors: Seo Jung HAN, Tae Bo SIM, Do Hee OH, Jae Eun CHEONG, Dong Keon HWANG